0000899243-20-032576.txt : 20201202
0000899243-20-032576.hdr.sgml : 20201202
20201202190512
ACCESSION NUMBER: 0000899243-20-032576
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20201202
DATE AS OF CHANGE: 20201202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hodges Philip
CENTRAL INDEX KEY: 0001705562
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32587
FILM NUMBER: 201365204
MAIL ADDRESS:
STREET 1: 19 FIRSTFIELD RD., SUITE 200
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-30
0
0001326190
Altimmune, Inc.
ALT
0001705562
Hodges Philip
C/O ALTIMMUNE, INC., 910 CLOPPER ROAD,
SUITE 201S
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock, par value $0.0001
2020-11-30
4
S
0
2500
12.00
D
14731
D
Common Stock, par value $0.0001
2020-12-01
4
S
0
1227
13.54
D
0
I
See Footnote
Common Stock, par value $0.0001
17848
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.51 to $13.59, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The shares of Common Stock are owned directly by Redmont Venture Partners, Inc. The reporting person has sole voting and dispositive control with respect to all securities held by Redmont Venture Partners, Inc. and may be deemed to be the beneficial owner of the securities held by Redmont Venture Partners, Inc. The reporting person disclaims beneficial ownership of the securities held by Redmont Venture Partners, Inc. except to the extent of his pecuniary interest therein.
The shares of Common Stock are owned directly by Paradigm Venture Partners, L.P. The reporting person has sole voting and dispositive control with respect to all securities held by Paradigm Venture Partners, L.P. and may be deemed to be the beneficial owner of the securities held by Paradigm Venture Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by Paradigm Venture Partners, L.P. except to the extent of his pecuniary interest therein.
/s/ William Brown, as Attorney-in-Fact
2020-12-02